Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) maintenance as monotherapy or in combination with bevacizumab (BEV) for non-small cell lung cancer (NSCLC) previously treated with chemotherapy Meeting Abstract
| Authors: | Rizvi, N. A.; Antonia, S. J.; Shepherd, F. A.; Chow, L. Q.; Goldman, J.; Shen, Y.; Chen, A. C.; Gettinger, S. |
| Abstract Title: | Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) maintenance as monotherapy or in combination with bevacizumab (BEV) for non-small cell lung cancer (NSCLC) previously treated with chemotherapy |
| Meeting Title: | 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 90 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2014 Oct 30-Nov 1 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-11-15 |
| Start Page: | S32 |
| Language: | English |
| ACCESSION: | WOS:000346413500069 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2014.08.206 |
| Notes: | Meeting Abstract: 167 -- Chicago Multidisciplinary Symposium in Thoracic Oncology -- OCT 30-NOV 01, 2014 -- Chicago, IL -- 5 -- Source: Wos |
